Your browser doesn't support javascript.
loading
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist.
Benichou, Olivier; Coskun, Tamer; Gonciarz, Malgorzata D; Garhyan, Parag; Adams, Andrew C; Du, Yu; Dunbar, James D; Martin, Jennifer A; Mather, Kieren J; Pickard, Richard T; Reynolds, Vincent L; Robins, Deborah A; Zvada, Simbarashe P; Emmerson, Paul J.
Afiliação
  • Benichou O; Eli Lilly and Company, Neuilly-sur-Seine 92521, France.
  • Coskun T; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Gonciarz MD; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Garhyan P; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Adams AC; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Du Y; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Dunbar JD; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Martin JA; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Mather KJ; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Pickard RT; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Reynolds VL; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Robins DA; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Zvada SP; Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Emmerson PJ; Eli Lilly and Company, Indianapolis, IN 46285, USA. Electronic address: paulemmerson@lilly.com.
Cell Metab ; 35(2): 274-286.e10, 2023 02 07.
Article em En | MEDLINE | ID: mdl-36630958

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Redução de Peso / Obesidade Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Redução de Peso / Obesidade Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article